Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 20, 2011PLoS ONEOpen Access

Lestaurtinib Inhibition of the JAK/STAT Signaling Pathway in Hodgkin Lymphoma Inhibits Proliferation and Induces Apoptosis

View Full Paper
Ask AI
Bookmark
Share

Authors

TDTania DíazANAlfons NavarroGFGerardo Ferrer

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Díaz et al. (2011) studied this question.

synapsesocial.com/papers/6a72d32e5d37378ac1df7005https://doi.org/10.1371/journal.pone.0018856
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Risk, Cure and Complications in Advanced Hodgkin Disease2007 · 30 citations
  2. 2Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders2007 · 252 citations